Fumonisins are mycotoxins that naturally occur as contaminants in grains that are destined for animal and human consumption. These mycotoxins cause hepatotoxic, nephrotoxic, carcinogenic, teratogenic, immunotoxic, and neurotoxic effects in different intensities based on dose, time of exposure, and animal species. In the present study, male Wistar rats were fed between postnatal days 21 and 63 with diets that contained fumonisins B1 + B2 at concentrations of 1 and 3 mg/kg. The objective of the present study was to evaluate the effects of fumonisins on food intake, growth, weight gain, serum activity of the alanine aminotransferase and aspartate aminotransferase enzymes, and quantitative and morphometric parameters of myenteric neurons in the jejunum that are immunoreactive to HuC/D protein and neuronal nitric oxide synthase enzyme (nNOS). Diets that contained fumonisins did not significantly alter food intake or body and blood parameters. We did not observe significant differences in the neuronal density and proportion of nitrergic neurons but found a significant reduction of cell body areas in both neuronal populations. This study is the first to report the effects of fumonisins in the enteric nervous system. The possible mechanisms by which fumonisins impair neuronal development and the use of the enteric nervous system as a tool for the study of the neurotoxic effects of fumonisins are discussed. In conclusion, fumonisin-containing food negatively affected the growth of myenteric neurons.
Introduction
Fumonisins are mycotoxins that are produced by several fungus species, especially Fusarium verticillioides and Fusarium proliferatum, which produce large amounts of these mycotoxins and are present in several places in the world as contaminants in corn plantations (Voss et al., 2007) . Streit et al. (2013) estimated that 50-63% of all grains produced for livestock feeding in the world are contaminated with fumonisins with a worldwide average of 0.914 mg/kg. In positive samples, the average level of fumonisins was 1.689 mg/kg, and the maximal level was approximately 77.502 mg/kg. Contamination with mycotoxins in grain plantations has attracted economic and scientific interest because these plantations are widely used for livestock and human feeding. Several countries have implemented laws that limit the maximal levels of fumonisins and other mycotoxins that are allowed in foods for human and animal consumption. The limits established by law are generally obtained by extrapolating experimental data, and a revision of permissible levels may be necessary based on new data that become available (Voss et al., 1996) .
Fumonisins were isolated and chemically characterized for the first time in 1988. Since then, 28 analogs have been described. Fumonisin B 1 (FB1) is the most abundant analog representing 70-80% of the total amount. Fumonisin B 2 (FB2) represents 15-25%, and the remaining analogs occur in low amounts (Rheeder et al., 2002) . Despite almost 30 years of research, the mechanism of action of fumonisins is not yet fully understood. Wang et al. (1991) reported that FB1 is a potent inhibitor of ceramide synthase, a key enzyme in the de novo synthesis and turnover of complex sphingolipids, such as sphingomyelin and glycosphingolipids, which participates in the composition of cellular membranes. In cells exposed to fumonisins, the synthesis of ceramide is reduced with a consequent decrease in the amount of sphingolipids and increase in their precursors, sphinganine and sphingosine. In addition to their structural role in cellular membranes, sphingolipids and their metabolic precursors participate in cellular signaling (Soriano et al., 2005) . Thus, alterations caused by fumonisins in the metabolism of sphingolipids impact other metabolic pathways, thereby leading to alterations in development, morphology, and cell survival (Merril et al., 1997) .
The consumption of foods that are naturally contaminated with fumonisins is related to the development of porcine lung edema and equine leukoencephalomalacia (Waes et al., 2005) , which is a disease characterized by necrosis of the brain hemispheres. In humans, epidemiological studies indicate a relationship between the ingestion of fumonisins and an increased incidence of defects in neural tubes (Waes et al., 2005) . The intake of fumonisins may also be related to neurodegenerative diseases, such as multiple sclerosis, Alzheimer's disease, and Parkinson's disease (Kovačić et al., 2009; Purzycki and Shain, 2010) . Several studies have been conducted with the objective of clarifying the mechanisms by which fumonisins induce toxicity in the nervous system (Domijan, 2012) . However, until now, such studies have focused on the effects on the central nervous system and rarely investigated the effects on the peripheral nervous system. Despite evidence that fumonisins affect the digestive system (Bouhet and Oswald, 2007) leading to alterations in intestinal absorption, increased susceptibility to infections, and alterations in the intestinal immune response, no study of which we are aware of has investigated the effect of these mycotoxins on the enteric nervous system, which is responsible for the intrinsic innervation of this system.
The enteric nervous system is the more complex portion of the peripheral nervous system. It is indispensable for maintaining homeostasis in the digestive system and an excellent model for the study of the nervous system as a whole (Anderson et al., 2006) . Considering that exposure to neurotoxic substances during childhood can cause neurological problems later in development (Kovačić et al., 2009 ), the present study evaluated the effects of a fumonisin-contaminated diet (1 and 3 mg/kg fumonisin) on the myenteric plexus of the jejunum in developing rats.
Material and methods
The Ethical Committee on Animal Experimentation of the Universidade Estadual de Maringá (protocol no. 044/2010) approved the procedures in this study that involved the use of animals.
Animals and experimental design
Thirty male Wistar rats (Rattus novergicus), which were 21 days of age and with approximately 50 ± 5 g body weight, were used. The animals were maintained in plastic cages with five animals per cage under controlled light (12 h/12 h light/dark cycle) and temperature (22 ± 2°C).
The animals were randomly separated into three experimental groups: F0 (fed a diet without fumonisins), F1 (fed a diet with 1 mg/kg fumonisins [FB1 + FB2]), and F3 (fed a diet with 3 mg/kg fumonisins [FB1 + FB2]). The animals had ad libitum access to food and water. Each experimental group was composed of 10 animals. Five of the animals in each group were euthanized 15 days after the experiment began (36 days old), and the other five were euthanized 42 days after the experiment began (63 days old).
Experimental diets
For the preparation of the base diet (Table 1) , corn, wheat bran, and soybeans were ground in a knife mill with a sieve (0.50 mm diameter particle size) and mixed by hand with the other ingredients. For the production of the diets with fumonisins, we added a sterilized culture medium of the fungus F. verticillioides, strain MRC 826, to the base diet, which was mixed again and homogenized. The Laboratório de Análises Micotoxicológicas (LAMIC) of the Universidade Federal de Santa Maria (UFSM), Rio Grande do Sul, Brazil, provided the culture medium. The food was then pelleted and dried in an oven with forced ventilation (55°C) for 24 h.
Samples of each type of diet were sent to LAMIC for qualitative and quantitative analyses of fumonisins using liquid chromatography coupled with sequential mass spectrometry (LC-MS/MS). The analysis of the diet of the F0 group revealed very low levels of FB1 (0.159 mg/kg) and the absence of FB2. The analysis of the diet of the F1 group revealed a mean level of fumonisins of 0.996 mg/kg (0.729 mg/kg FB1 and 0.267 mg/kg FB2). The analysis of the diet of the F3 group revealed a mean level of fumonisins of 2.819 mg/kg (2.100 mg/kg FB1 and 0.719 mg/kg FB2).
The animals' body weight and food intake were measured weekly. Food intake was evaluated by subtracting the remaining food from the total food given to the animals. We calculated the average food intake per 100 g of body weight based on these data. We calculated fumonisin intake per kg of body weight per day based on this average food intake and the average fumonisin concentrations in the foods. Lee's index, which was an indicator of the relationship between size and body mass (similar to the body mass index in humans), was calculated using the following formula: [(body weight in g) 1/3 / nasoanal distance in cm] × 1000 (Stephens, 1980) .
Euthanasia and collection of biological samples
Fifteen days after the experiment began, five animals in each group were euthanized with an intravenous injection of sodium thiopental (120 mg/kg of body weight). Blood samples were collected to analyze the serum activity of the alanine aminotransferase (ALT) and aspartate aminotransferase (AST) enzymes using standardized commercial kits (Gold Analisa, Belo Horizonte, Brazil). Forty-two days after the experiment began, the other five animals in each group underwent the same procedures for euthanasia, blood collection, and analysis. Additionally, the small intestine was removed, and its area was calculated by multiplying the width by the length. Jejunum samples from each animal were collected from the proximal portion of the organ and utilized for the study of myenteric neurons.
Immunohistochemistry
The jejunum samples were washed with 0.1 M phosphate-buffered saline (pH 7.4), filled with fixative (4% paraformaldehyde in 0.1 M PBS, pH 7.4), tied at the extremities, immersed in the same fixative, and maintained under refrigeration at 4°C for 2 h. The extremities were then opened. The samples were washed twice with 0.1 M PBS (pH 7.4) and stored under refrigeration at 4°C in 0.1 M PBS (pH 7.40) with the addition of 0.08% sodium azide (Sigma-Aldrich, St. Louis, MO, USA). Whole mounts containing the muscularis externa, serosa and the myenteric plexus were obtained through sample microdissection under a stereomicroscope. The whole mounts were subjected to double immunostaining for the detection of HuC/D protein (Lin et al., 2002) and neuronal nitric oxide synthase enzyme (nNOS) (Wrozs et al., 1997) . The whole mounts were washed twice with 0.01 M PBS (pH 74) with 0.5% Triton X-100 (Sigma-Aldrich, St. Louis, MO, USA) for 10 min per wash and immersed for 1 h in a solution that contained 0.01 M PBS (pH 7.4), 0.5% Triton X-100, 2% bovine serum albumin (BSA; Sigma-Aldrich, St. Louis, MO, USA), and 10% goat serum to prevent nonspecific binding. Subsequently, the tissues were incubated at room temperature with constant shaking for 48 h in a solution that contained 0.01 M PBS (pH 7.4), 0.5% Triton X-100, 2% BSA, 2% goat serum, and mouse anti-HuC/D (Life Technologies, Carlsbad, CA, USA) and rabbit anti-nNOS (Santa Cruz Biotechnology, Santa Cruz, CA, USA) primary antibodies, which were both diluted at 1:500. The whole mounts were then washed three times with 0.01 M PBS (pH 7.4) and 0.5% Triton X-100 for 5 min per wash and incubated for 2 h at room temperature with Alexa Fluor 488 anti-mouse (Life Technologies, Carlsbad, CA, USA) and Alexa Fluor 546 anti-rabbit (Life Technologies, Carlsbad, CA, USA) secondary antibodies, which were both diluted at 1:500 in a solution of 0.01 M PBS (pH 7.4), 0.5% Triton X-100, 2% BSA, and 2% goat serum. The whole mounts were then washed with 0.01 M PBS (pH 7.4) and placed between lamina and cover slip with mounting medium for immunohistochemistry fluorescence, ProLong® Gold (Life Technologies, Carlsbad, CA, USA).
Quantitative and morphometric neuronal analysis
Myenteric neurons that were immunoreactive to HuC/D and nNOS were counted in 32 images (12,48 mm 2 ) for each animal in each experimental group. The images were acquired with an Axioskop 2 Plus (Zeiss) microscope equipped with an HBO 100 (Zeiss) fluorescence system and AxioCam HRc (Zeiss) camera for fluorescent image capture. The images were captured using an objective lens with 20× magnification. All of the images were taken from the intermediary region of the intestinal circumference to avoid interference from natural variations in neuronal density along the intestinal circumference. The neuronal quantification was performed using the ImageTool 3.0 software (University of Texas Health Science Center, San Antonio, TX, USA). The results were used to calculate neuronal density per cm 2 . For the morphometric analyses, the areas of the cell body profiles (μm 2 ) of 150 HuC/D-immunoreactive neurons and 150 nNOSimmunoreactive neurons were measured per animal. The neuronal measurements were performed using the same images that were used for quantitative analysis using the ImageTool 3.0 software. The results were used to calculate the average area of cell bodies and distribution of the frequency as a function of the cell body area in arbitrary intervals of 50 μm 2 .
Statistical analysis
The data were analyzed for normality using the Shapiro-Wilk test and R 2.15.2 software. The means were compared using analysis of variance (ANOVA) with Tukey's post hoc test for multiple comparisons. The frequency distributions were analyzed using the χ 2 test and Prism 6.0 software (GraphPad, San Diego, CA, USA). The level of significance was 5%, and the results are expressed as mean ± standard deviation.
Results

Body parameters and food intake
No mortality or signs of acute intoxication, such as fur bristling or drooping, mucosal or tail cyanosis, lethargy, or anorexia, were observed during the experimental period. Table 2 shows the data for variations of body parameters and food intake. No significant group differences in body weight gain, Lee's index, or food intake were observed during the experiment. The average fumonisin consumption was 17.11 ± 2.13, 103.30 ± 12.25, and 311.20 ± 40.89 μg/kg of body weight per day in the F0, F1, and F3 groups, respectively. The analysis did not reveal significant differences in serum biochemical parameters (Table 3 ). The average areas of the small intestine were 119.4 ± 26.04, 100.20 ± 9.76, and 112.7 ± 14.32 cm 2 in the F0, F1, and F3 groups, which were not significantly different.
Neuronal analysis
3.2.1. Neuronal quantification Double immunostaining revealed that the fumonisin-containing diet did not alter the morphological organization of the myenteric plexus, with the majority of neurons located in the ganglia (Fig. 1) . The neuronal counts in an area of 12.48 mm 2 per animal were extrapolated to determine neuronal density (Table 4) . Because no differences in the intestinal areas were found (see section 3.1), the use of a correction factor for neuronal density was unnecessary. No significant differences in neuronal density in the general (HuC/D-immunoreactive) and nitrergic (nNOS-immunoreactive) populations were observed.
Neuronal morphometry
The morphometric analyses revealed that the fumonisin-containing diets significantly reduced the average area of the cellular profile for both the general population of myenteric neurons and the nitrergic subpopulation (Table 4 , Fig. 1 ). The data were distributed as frequency classes at arbitrary intervals of 50 μm 2 indicating a range of variation in the neuronal area. Figs. 2 and 3 present the histograms of the frequency distributions and statistical results. 
Discussion
The 1 and 3 mg/kg fumonisin concentrations in the food used in the present study are equivalent to food preparations that contain corn in a proportion of 34% (Table 1 ) with fumonisin concentrations of 3 and 9 mg/kg. Corn harvests with these levels of contamination are common in several parts of the world (Rodrigues and Naehrer, 2012; Yazdanpanah et al., 2006) . Thus, the concentrations of fumonisins used in the present study represent values that are commonly found in food for livestock and human consumption (Zimmer et al., 2008) . For humans, different feeding habits and socioeconomic conditions determine the quantity of corn-based food in the diet. In regions where corn is the base for food, the consumption of a diet rich in corn, with fumonisin concentrations of approximately 3 mg/kg, has been suggested to cause high indices of esophageal cancer in humans (van der Westhuizen et al., 2003) . Therefore, various countries have laws that limit the maximal concentration of fumonisins to 3 mg/kg in products that are destined for human consumption. For some animal species, laws limit the concentrations of fumonisins in the diet to values that are less than the concentrations used in the present study. For example, the United States Food and Drug Administration limits the fumonisin concentration to 1 mg/kg for rabbits and horses (FDA, 2001) .
In the present study, we opted to use 21-to 63-day-old animals, which are in a developmental phase that is equivalent to late childhood, adulthood, and the beginning of the animals' reproductive lives (Nistiar et al., 2012) . These are critical periods for development, especially for the nervous system. Childhood is also a period of increased intake of corn-based foods. Thus, laws that limit mycotoxins are more exigent for foods that are destined for children. For example, the European Union and Brazil limit the amount of fumonisins to 0.2 mg/kg in foods for children (BRASIL, 2011; EC, 2007) .
The intake of fumonisins in all of the experimental groups in the present study exceeded the limit of 2 μg/kg of body weight per day that is recommended for humans by the United Nations Organization (FAO/WHO, 2011). In the F3 group, the average intake of fumonisins over the course of the experiment was 311.20 ± 40.89 μg/kg of body weight per day, a value close to the consumption by human populations with high levels of fumonisins, such as in the rural areas in South Africa (Marasas, 2001) . Notably, the diets that contained fumonisin levels of 1 and 3 mg/kg neither affected food intake nor impaired the animals' growth. The rats in the F1 and F3 groups did not present a reduction of weight gain or the Lee's index. This result is consistent with Gelderblom et al. (2001) , who reported that rats fed for up to 14 months with a diet that contained FB1 at levels of 1, 10, and 25 mg/kg did not present a reduction of weight gain or food intake. Gelderblom et al. (1994) observed a reduction of food intake in rats fed diets that contained 250, 500, and 750 mg/kg FB1 compared with animals that were fed a diet without fumonisins. However, this reduction was only seen in the first 2 weeks of the experiment. After this time, food intake was equivalent, and no significant group differences in the body mass were observed at the end of the experiment.
In all of the experimental groups, food intake as a proportion of body mass peaked during the first three weeks of the experiment, which corresponds to more rapid animal growth. After this time, food intake decreased until the end of the experiment. Thus, food intake in the third week of the experiment was an average of 40% higher than food intake in the sixth week of the experiment. The increase in food intake relative to body mass during the first weeks of the experiment resulted in an increase in the ingestion of fumonisins as a proportion of body mass. Consequently, in developing animals, fumonisin intoxication develops in two phases: an initial phase with a proportionally higher intake of the toxin and a subsequent phase with a gradual reduction of toxin intake as a proportion of body mass. 
Table 4
Neuronal density and area of the cellular profile of myenteric neurons of the jejunum in rats fed for 42 days with diets without the addition of fumonisins (F0) or with the addition of 1 mg/kg fumonisins (F1) or 3 mg/kg fumonisins (F3).
Groups
Neuronal To evaluate whether an increase in the ingestion of fumonisins during the initial period of the experiment could cause hepatic lesions in the animals, five animals in each group were euthanized 15 days after the experiment began, and blood samples were analyzed to determine the AST and the ALT activity. Forty-two days after the experiment began, the same blood tests were performed in the remaining five animals in each experimental group (Table 3) . We did not observe significant differences in ALT or AST after 15 or 42 days of being fed the fumonisin-containing diet. Gelderblom et al. (2001) observed hepatic lesions, apoptosis, the proliferation of ductule epithelial cells and fibrosis, in rats chronically treated for 24 months with 1, 10, and 25 mg/kg FB1 in the diet. Only AST was increased and only at FB1 doses of 10 and 25 mg/kg. Thus, the lower doses and shorter time of administration in the present study justified the absence of differences in the activity of the AST and ALT enzymes.
During the entire experimental period, we did not observe symptoms of gastrointestinal problems, such as diarrhea. However, mild signs of gastrointestinal problems are difficult to evaluate in animals. In humans, Bhat et al. (1997) reported an outbreak of fumonisin intoxication in India that was caused by the consumption of corn and sorghum contaminated with fumonisins, which was characterized by intestinal symptoms, including diarrhea, abdominal pain, and borborygmus. The relationship between fumonisin consumption and the development of esophageal cancer in humans has been studied since investigations of the incidence of this type of cancer in the Transkei region of South Africa led to the discovery of fumonisins (Rheeder et al., 1992) . In the present study, we did not observe any macroscopic differences, such as tumors, in the entire gastrointestinal tract, with no significant difference in the size or mass of the small intestine in the F1 and F3 groups compared with the F0 group.
According to Grenier and Applegate (2013) , although the intestine is the principal route of mycotoxin absorption, the literature on the effects of mycotoxins in intestinal physiology is scarce. Bouhet and Oswald (2007) reported that fumonisins impair intestinal absorption, increase the susceptibility to infections, and alter the intestinal immune response. Although several studies have investigated the neurotoxic effects of fumonisins, they focused on the central nervous system, with no information on the effects of fumonisins on the enteric nervous system, which represents the principal mechanism of neuronal control of gastrointestinal tract function. Fig. 1 shows that the intake of foods with fumonisins between 21 and 63 days of life at the doses used herein did not alter the typical morphological arrangement of the myenteric plexus, and the neurons maintained their ganglion localization. Table 4 illustrates that the consumption of fumonisin-containing diets in the F1 and F3 groups did not lead to significant alterations in the density of the general population of myenteric neurons, HuC/D-immunoreactive, or the population of nitrergic neurons, nNOS-immunoreactive. No alterations were found in the proportion of nitrergic neurons compared with the total neuronal population. The nitrergic population represented an average of 28% of the neurons. Considering that myenteric neurons are a nonrenewable cellular population (Souza et al., 1993) , the present results demonstrate that a diet that contains fumonisins at doses of 1 and 3 mg/kg did not cause neuronal death in the myenteric plexus in rats.
Several studies have investigated the effects of fumonisins on neuron survival. Generally, however, these studies used in vitro approaches, unnatural forms of inoculation, or very high doses that are not usually found in real situations. Stockmann-Juvala et al. (2004) studied the viability of human SH-SY5Y neuroblastoma cells and mouse GT1-7 hypothalamic cells in cultures that contained FB1 at doses of 1, 10, and 100 μM for 48, 72, and 144 h and observed a reduction of cell viability only at the highest dose. exposed N2A neuroblastoma cells and BALB/c mouse cortical neurons to doses of FB1 up to 50 μM for periods of up to 4 days for N2A cells and 8 days for cortical neurons and did not observe a reduction of cell viability. exposed female mice to 10 and 100 μg FB1 for 7 days subcutaneously or by direct injection in the brain ventricles and observed brain cortex neurodegeneration with the highest dose. Given the discrepant results in the literature, Domijan (2012) concluded that the cytotoxic effects of fumonisins in the cells of the nervous system tissue are determined by the duration of exposure, concentration, cell type, brain region, and animal species.
Although we did not observe a reduction of neuronal density, we did observe (Table 4 , Figs. 2 and 3) that the fumonisin-containing diet affected the size of myenteric neurons in both the general and nitrergic populations, with a significant reduction of the average cellular profile in the F3 group compared with the F0 group for the general population and a significant reduction of the nitrergic population in the F1 and F3 groups compared with the F0 group. Despite being reduced in size, nitrergic neurons kept their typical morphology of Dogiel type I neurons.
Myenteric neurons exhibit large variability in size and shape, and the use of the average number of myenteric neurons does not adequately represent the possible variations in the size of these neurons. Therefore, the neuronal measurement data were converted into frequency distributions with classes at arbitrary intervals of 50 μm 2 , which are presented as histograms in Figs. 2 and 3 . This analysis indicated a higher concentration of neurons in the smaller cell profile class in the F1 and F3 groups compared with the F0 group, reflected by a leftward shift of the histogram.
Myenteric neurons undergo intense neuroplasticity during the organism's growth and aging. According to Marese et al. (2007) , the length of the small intestine increases by approximately 400% between 21 and 60 days of age, and the neuronal density of the myenteric plexus decreases by 50%. However, the average size of neurons increases by 53%. According to these authors, this process extends throughout life in a neuroplastic mechanism whereby hypertrophy of the remaining neurons occurs concomitantly with neuronal death to warrant the innervation of the gastrointestinal tract for functional maintenance. The present results indicated a significant reduction of the average area of the cellular profile and an increase in the number of small neurons in the myenteric plexus in rats that were fed a diet that contained fumonisins at doses of 1 and 3 mg/kg, indicating that fumonisin intake negatively influences neuroplastic mechanisms in the small intestine in rats between 21 and 63 days of age. Because the size of enteric neurons is directly related to the size of their area of innervation, the observation that fumonisin reduced the neuronal area without affecting the size of the intestine leads to the hypothesis that this mycotoxin can impair the ability of neurons to control their innervation targets, thus impairing the function of the gastrointestinal tract. Heuckeroth et al. (1999) found results in neurturin growth factor knockout mice that were similar to those observed in the present study (i.e., a reduction of the enteric neuronal area, no significant reduction of the number of neurons, and maintenance of the size of the organs of the gastrointestinal tract). These animals displayed a reduction of the release of neurotransmitters and decreased gastrointestinal motility. In the present study, no signs of gastrointestinal distress were observed in the animals, but further studies with higher doses of fumonisins and direct analyses of neurotransmitter systems may reveal alterations in the function of the gastrointestinal tract.
The present results indicated that a fumonisin-containing diet affected the growth process of myenteric neurons, which is consistent with several studies of the effect of these mycotoxins on the development of neurons in the central nervous system. Kwon et al. (1997) gave Sprague-Dawley rats subcutaneous injections of FB1 at doses of 0.4 and 0.8 mg/kg between postnatal days 3 and 12 and found a significant reduction of myelination in the corpus callosum and diencephalon, concluding that the process of brain myelination is affected by fumonisins. Harel and Futerman (1993) collected hypothalamic neurons from embryonic day 18 Wistar rats and maintained them in culture with the addition of 10 μM FB1. They found an intense blockade of axonal growth. Schwarz and Futerman (1998) utilized methodology that was similar to Harel and Futerman (1993) but added 50 or 200 μM FB1 to the culture medium. They observed a 25% reduction of the speed of dendrite growth and an intense reduction of dendrite extension.
The mechanisms by which fumonisins alter survival, development, and the morphology of neuronal cells are not yet fully understood. The only known binding site for fumonisins is ceramide synthase. This enzyme catalyzes a key reaction in the de novo pathway of sphingolipid synthesis and also exerts actions in the turnover pathway of complex membrane sphingolipids. Fumonisins cause reversible inhibition of ceramide synthase (Wang et al., 1991) . Utilizing an in vitro approach, Merril et al. (1993) tested and confirmed the hypothesis that fumonisins block the synthesis of sphingolipids in neurons. The inhibition of ceramide synthase reduced the amount of membrane sphingolipids, such as sphingomyelin and glycosphingolipids, and increased the concentrations of sphinganine, a precursor in the de novo pathway, and sphingosine, an intermediate in the turnover pathway (Soriano et al., 2005) . In addition to their role as structural lipids in the cell membrane, sphingolipids and various precursors and intermediates of their biochemical pathways, such as ceramide, sphingosine, sphinganine, and their phosphorylated derivatives, act as cellular messengers that trigger several processes that affect neuronal development, morphology, function, and survival (Merrill et al., 1997) . Thus, some authors have attributed the effects of fumonisins on the nervous system to the depletion of complex sphingolipids in neuronal membranes (Harel and Futerman, 1993) . Another hypothesis involves the accumulation of bioactive precursors and intermediates (Colombaioni and GarciaGil, 2004) . Other evidence suggests that the effects of fumonisins may be mediated by immunological alterations , an anti-nutritional effect (Carratù et al., 2003) , oxidative stress (Stockmann-Juvala et al., 2004) , and mitochondrial dysfunction (Domijan and Abramov, 2011) .
Future studies will likely expand and clarify the effects of fumonisins on the nervous system. These studies may lead to revisions of laws related to the maximum tolerable limits of mycotoxin exposure and new discoveries in the physiology of the nervous system. Because of the relatively simple morphologic arrangement of the enteric system, its large biochemical complexity, its functional importance, its easy accessibility, and the availability of several techniques for neuronal assessment, the enteric nervous system is a valuable tool in the study of the effects of mycotoxins on the nervous system in general.
